SK284982B6 - Spôsob prípravy zlúčenín podporujúcich sekréciu rastového hormónu - Google Patents

Spôsob prípravy zlúčenín podporujúcich sekréciu rastového hormónu Download PDF

Info

Publication number
SK284982B6
SK284982B6 SK230-2000A SK2302000A SK284982B6 SK 284982 B6 SK284982 B6 SK 284982B6 SK 2302000 A SK2302000 A SK 2302000A SK 284982 B6 SK284982 B6 SK 284982B6
Authority
SK
Slovakia
Prior art keywords
formula
compound
methyl
oxo
pyridin
Prior art date
Application number
SK230-2000A
Other languages
English (en)
Slovak (sk)
Other versions
SK2302000A3 (en
Inventor
Frank Robert Busch
Charles Kwok-Fung Chiu
Clifford Nathaniel Meltz
Ronald James Post
Peter Robert Rose
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of SK2302000A3 publication Critical patent/SK2302000A3/sk
Publication of SK284982B6 publication Critical patent/SK284982B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
SK230-2000A 1999-02-26 2000-02-21 Spôsob prípravy zlúčenín podporujúcich sekréciu rastového hormónu SK284982B6 (sk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12274599P 1999-02-26 1999-02-26

Publications (2)

Publication Number Publication Date
SK2302000A3 SK2302000A3 (en) 2000-11-07
SK284982B6 true SK284982B6 (sk) 2006-03-02

Family

ID=22404505

Family Applications (1)

Application Number Title Priority Date Filing Date
SK230-2000A SK284982B6 (sk) 1999-02-26 2000-02-21 Spôsob prípravy zlúčenín podporujúcich sekréciu rastového hormónu

Country Status (44)

Country Link
US (2) US6541634B2 (fr)
EP (2) EP1031575B1 (fr)
JP (3) JP3437813B2 (fr)
KR (2) KR100372063B1 (fr)
CN (3) CN1515570A (fr)
AP (1) AP1221A (fr)
AR (2) AR029617A1 (fr)
AT (1) ATE277944T1 (fr)
AU (1) AU764122B2 (fr)
BG (1) BG104175A (fr)
BR (2) BRPI0000967B8 (fr)
CA (1) CA2299495C (fr)
CO (1) CO5160252A1 (fr)
DE (1) DE60014212T2 (fr)
DK (1) DK1031575T3 (fr)
DZ (1) DZ3018A1 (fr)
EA (1) EA003218B1 (fr)
EE (1) EE200000193A (fr)
ES (1) ES2226712T3 (fr)
GT (1) GT200000018A (fr)
HK (1) HK1030219A1 (fr)
HN (1) HN2000000021A (fr)
HR (1) HRP20000103A2 (fr)
HU (1) HUP0000907A3 (fr)
ID (1) ID24861A (fr)
IL (2) IL157103A (fr)
IN (1) IN192352B (fr)
IS (1) IS5380A (fr)
MA (1) MA25072A1 (fr)
NO (1) NO20000965L (fr)
NZ (1) NZ503062A (fr)
OA (1) OA11325A (fr)
PA (1) PA8491201A1 (fr)
PE (1) PE20001550A1 (fr)
PL (1) PL338628A1 (fr)
PT (1) PT1031575E (fr)
SG (1) SG90096A1 (fr)
SI (1) SI1031575T1 (fr)
SK (1) SK284982B6 (fr)
TN (1) TNSN00035A1 (fr)
TR (1) TR200000536A2 (fr)
TW (2) TW200718702A (fr)
UA (1) UA70306C2 (fr)
ZA (1) ZA200000888B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1132388A3 (fr) * 2000-03-09 2004-03-03 Pfizer Products Inc. Métabolites de hexahydropyrazolo[4,3-c]pyridines
AU2001264977B2 (en) 2000-05-30 2005-04-14 Merck & Co., Inc. Melanocortin receptor agonists
AU2003237595A1 (en) * 2003-05-26 2004-12-13 Biocon Limited Process for the preparation of s(+)-2-ethoxy-4-(n-{1-(2-piperidinophelyl)-3-methyl-1- butyl} aminocarbonylmethyl)benzoic acid derivatives
WO2005027913A1 (fr) * 2003-09-19 2005-03-31 Pfizer Products Inc. Compositions pharmaceutiques et methodes de traitement consistant en des associations d'un derive de la 2-alkylidene-19-nor-vitamine d et d'un secretagogue de l'hormone de croissance
US9117477B2 (en) 2013-05-08 2015-08-25 HGST Netherlands B.V. Perpendicular magnetic recording media having novel seed layer
TWI629982B (zh) 2013-05-28 2018-07-21 拉夸里亞創藥股份有限公司 多晶型形式
CN109320515A (zh) * 2018-11-22 2019-02-12 常州大学 一种Capromorelin手性中间体的不对称合成方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8610980D0 (en) 1986-05-06 1986-06-11 Ici America Inc Heterocyclic fused tricyclic compounds
GB8901423D0 (en) 1989-01-23 1989-03-15 Fujisawa Pharmaceutical Co Pyrazolopyridine compound and processes for preparation thereof
US5536716A (en) 1992-12-11 1996-07-16 Merck & Co., Inc. Spiro piperidines and homologs which promote release of growth hormone
AU1172995A (en) 1993-11-09 1995-05-29 Merck & Co., Inc. Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone
US5609150A (en) 1995-04-18 1997-03-11 Maged; Jeffrey M. Method for dilating respiratory passages
TW432073B (en) 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
AU2334097A (en) 1996-03-21 1997-10-10 Merck & Co., Inc. 4-spiroindoline piperidines promote release of growth hormone
WO1997036873A1 (fr) 1996-04-03 1997-10-09 Merck & Co., Inc. Piperidines, pyrrolidines et hexahydro-1h-azepines declenchant la liberation de l'hormone de croissance
UA64751C2 (uk) * 1997-06-25 2004-03-15 Пфайзер Продактс Інк. Спосіб лікування інсулінової толерантності речовинами, які посилюють секрецію гормону росту (варіанти) та фармацевтична композиція (варіанти)
UA53716C2 (uk) 1997-06-25 2003-02-17 Пфайзер Продактс Інк. Тартратна сіль заміщеного дипептиду, спосіб її одержання, проміжні сполуки та спосіб їх одержання, фармацевтична композиція (варіанти), спосіб підвищення рівнів ендогенного гормону росту та спосіб лікування або профілактики захворювань (варіанти)
JP3514774B2 (ja) 1997-06-25 2004-03-31 ファイザー・インク 成長ホルモン分泌促進薬としてのジペプチド誘導体

Also Published As

Publication number Publication date
AU1947100A (en) 2000-08-31
HUP0000907A3 (en) 2001-05-28
EA003218B1 (ru) 2003-02-27
HUP0000907A2 (en) 2001-03-28
HN2000000021A (es) 2001-02-02
ID24861A (id) 2000-08-31
JP2003261565A (ja) 2003-09-19
PT1031575E (pt) 2004-11-30
CN1515570A (zh) 2004-07-28
BRPI0000967B8 (pt) 2021-12-07
IL134599A (en) 2006-12-10
DK1031575T3 (da) 2005-01-03
HRP20000103A2 (en) 2001-04-30
NO20000965D0 (no) 2000-02-25
TW200718702A (en) 2007-05-16
ATE277944T1 (de) 2004-10-15
AR029617A1 (es) 2003-07-10
GT200000018A (es) 2001-08-16
IL157103A (en) 2007-07-24
EA200000172A2 (ru) 2000-08-28
DE60014212T2 (de) 2005-12-15
EP1449842A1 (fr) 2004-08-25
OA11325A (en) 2003-10-27
BRPI0017522B1 (pt) 2013-09-24
PL338628A1 (en) 2000-08-28
JP3437813B2 (ja) 2003-08-18
BRPI0000967B1 (pt) 2012-06-12
PA8491201A1 (es) 2001-04-30
US20020002283A1 (en) 2002-01-03
CN1837205A (zh) 2006-09-27
KR100361783B1 (ko) 2002-11-22
AP2000001754A0 (en) 2000-03-31
BRPI0017522B8 (pt) 2021-05-25
CA2299495C (fr) 2010-06-15
US20030158414A1 (en) 2003-08-21
US6673929B2 (en) 2004-01-06
EA200000172A3 (ru) 2000-10-30
EE200000193A (et) 2000-10-16
EP1031575B1 (fr) 2004-09-29
EP1031575A1 (fr) 2000-08-30
TWI286142B (en) 2007-09-01
BRPI0017522A2 (fr) 2009-12-22
AU764122B2 (en) 2003-08-07
CN1137891C (zh) 2004-02-11
CA2299495A1 (fr) 2000-08-26
ES2226712T3 (es) 2005-04-01
BG104175A (bg) 2000-12-29
KR100372063B1 (ko) 2003-02-14
NZ503062A (en) 2001-07-27
AR053722A2 (es) 2007-05-16
CO5160252A1 (es) 2002-05-30
AP1221A (en) 2003-11-03
KR20020065455A (ko) 2002-08-13
HU0000907D0 (en) 2000-04-28
MA25072A1 (fr) 2000-10-01
SI1031575T1 (en) 2005-02-28
UA70306C2 (en) 2004-10-15
TR200000536A2 (tr) 2000-09-21
CN1270960A (zh) 2000-10-25
JP4051314B2 (ja) 2008-02-20
DE60014212D1 (de) 2004-11-04
IN192352B (fr) 2004-04-10
ZA200000888B (en) 2001-08-23
JP2000247974A (ja) 2000-09-12
JP2003327585A (ja) 2003-11-19
US6541634B2 (en) 2003-04-01
SG90096A1 (en) 2002-07-23
KR20010006698A (ko) 2001-01-26
PE20001550A1 (es) 2001-01-11
NO20000965L (no) 2000-08-28
HK1030219A1 (en) 2001-04-27
IS5380A (is) 2000-08-27
BRPI0000967A (pt) 2001-09-11
IL134599A0 (en) 2001-04-30
SK2302000A3 (en) 2000-11-07
DZ3018A1 (fr) 2004-03-20
TNSN00035A1 (fr) 2005-11-10
IL157103A0 (en) 2004-02-08

Similar Documents

Publication Publication Date Title
EP3952902A1 (fr) Formes posologiques et schémas de traitement pour des composés d'acides aminés
CA3093225A1 (fr) Composes d'acides amines et leurs procedes d'utilisation
EP2066667B1 (fr) Méthode de préparation de dérivés de pyrido[2,1-a]isoquinoline comprenant une résolution optique d'une énamine
EP2266991B1 (fr) Processus de production de dérivé de thiazole
WO2006063706A1 (fr) Nouveau procede pour la fabrication de derives d'acide 3-pyrrolidin-2-yl-propionique
SK284982B6 (sk) Spôsob prípravy zlúčenín podporujúcich sekréciu rastového hormónu
AU2018448845B2 (en) Method for producing dimethoxybenzene compound
JP2008518883A (ja) タンパク質キナーゼ阻害剤として有用な６−（２−アルキル−フェニル）−ピリド［２，３−ｄ］ピリミジン
CZ2000704A3 (cs) Způsob přípravy sloučenin podporujících sekreci růstového hormonu
EP1838660A2 (fr) Nouvelle synthese en une etape d'amines disubstituees utiles
MXPA00002031A (en) Process for preparing growth hormone secretagogues
US6197974B1 (en) Enantioselective synthesis of 3-aminopyrrolidines
US20050096466A1 (en) Process for the preparation of tetrazol-derived compounds as growth hormone secretagogues
WO2007067906A2 (fr) Inhibiteurs de la peptide deformylase

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20100221